How to Evaluate Claims About New Alzheimer’s Treatments
Evaluating claims about new Alzheimer's treatments requires a systematic approach focused on three fundamental questions: Is the treatment FDA-approved?
Category Diet
Could Biomarker Tests Create Confusion Without Counseling?
Yes, biomarker tests can absolutely create confusion without proper counseling. When someone receives results showing elevated amyloid or tau proteins in...
Why Alzheimer’s Patients May Need Different Treatment Paths
Alzheimer's disease is not a one-size-fits-all condition, and neither should its treatment be. Recent advances in blood testing, genetic screening, and...
Why One-Size-Fits-All Dementia Treatment May Not Work
One-size-fits-all dementia treatment does not work because dementia itself is not a single disease affecting everyone the same way.
How Genetic Risk, Biomarkers, and Lifestyle Could Shape Treatment
Genetic risk, biomarkers, and lifestyle factors work together to shape whether and how dementia treatments will work for an individual patient.
Could Future Brain Health Tests Screen for Several Disorders?
Yes, future brain health tests promise to screen for several disorders at once—and this isn't purely theoretical.
What Clinical Trials Reveal About Alzheimer’s Treatment Hopes
Clinical trials have revealed that a growing number of drug candidates can slow cognitive decline in early-stage Alzheimer's disease, though the effects...
Why Patients Should Be Cautious About Experimental Dementia Treatments
Experimental dementia treatments may seem like a promising path to recovery, especially when a loved one has received a diagnosis with few approved...
How Emerging Alzheimer’s Treatments Are Evaluated
Emerging Alzheimer's treatments are evaluated through a rigorous multi-stage process that combines clinical trials, regulatory oversight, and real-world...
Why New Alzheimer’s Treatments Need Careful Study
New Alzheimer's treatments need careful study because their modest benefits come with serious brain safety risks that require intensive monitoring, and...